R31NJMTE last accessed: 2022-11-04

ADNI
metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

Alzheimer’s Disease Neuroimaging Initiative
metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

Other names: IDA, Alzheimer's Disease Neuroimaging Initiative Image and Data Archive, ADNI Image and Data Archive, LONI Image and Data Archive, ADNI, Alzheimer’s Disease Neuroimaging Initiative

The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease (AD). ADNI researchers collect, validate and utilize data, including MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors of the disease. Study resources and data from the North American ADNI study are available through this website, including Alzheimer’s disease patients, mild cognitive impairment subjects, and elderly controls.

Webpage:

http://adni.loni.usc.edu

Licence:

Name: Resource specific
URL: http://adni.loni.usc.edu/data-samples/access-data/

Publications:

Publications
More detailed information about this field from each metasource.

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI)
PMID: 17476317
metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

The Alzheimer's disease neuroimaging initiative
PMID: 16443497
metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception
PMID: 23932184
metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
PMID: 26073027
metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

https://doi.org/10.1212/WNL.0b013e3181cb3e25
metasource: BiŌkeanós-Medsourcing
version: 0.0.1:2022-11-04T13:34:25.975929

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI) PubMed citations: 415.

415 articles citing: Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Conformal Prediction in Clinical Medical Sciences. PMID:35898853
MRI-Visible Perivascular Spaces Associated With Cognitive Impairment in Military Veterans With Traumatic Brain Injury Mediated by CSF P-Tau. PMID:35873253
Multimodal deep learning for Alzheimer's disease dementia assessment. PMID:35725739
A Novel Key Features Screening Method Based on Extreme Learning Machine for Alzheimer's Disease Study. PMID:35693342
Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease. PMID:35668104
Machine Learning Reveals a Multipredictor Nomogram for Diagnosing the Alzheimer's Disease Based on Chemiluminescence Immunoassay for Total Tau in Plasma. PMID:35645782
Lifespan Volume Trajectories From Non-harmonized T1-Weighted MRI Do Not Differ After Site Correction Based on Traveling Human Phantoms. PMID:35614930
ADataViewer: exploring semantically harmonized Alzheimer's disease cohort datasets. PMID:35598021
AD Resemblance Atrophy Index of Brain Magnetic Resonance Imaging in Predicting the Progression of Mild Cognitive Impairment Carrying Apolipoprotein E-ε4 Allele. PMID:35572149
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition. PMID:35571963
The Broad Range of Research in Alzheimer's Disease and Related Dementias. PMID:35562636
Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease. PMID:35466939
A Machine Learning Classifier for Predicting Stable MCI Patients Using Gene Biomarkers. PMID:35457705
Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer's disease. PMID:35443691
Machine learning for medical imaging: methodological failures and recommendations for the future. PMID:35413988
Quantification of amyloid PET for future clinical use: a state-of-the-art review. PMID:35389071
REGION SPECIFIC AUTOMATIC QUALITY ASSURANCE FOR MRI-DERIVED CORTICAL SEGMENTATIONS. PMID:35321153
Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort. PMID:35172755
Effect of head motion-induced artefacts on the reliability of deep learning-based whole-brain segmentation. PMID:35102199
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives. PMID:35005206
Applied machine learning in Alzheimer's disease research: omics, imaging, and clinical data. PMID:34881778
Dimensionality Reduction: Foundations and Applications in Clinical Neuroscience. PMID:34862528
Information Flow Pattern in Early Mild Cognitive Impairment Patients. PMID:34858306
Not all voxels are created equal: Reducing estimation bias in regional NODDI metrics using tissue-weighted means. PMID:34852276
Improved Alzheimer's Disease Detection by MRI Using Multimodal Machine Learning Algorithms. PMID:34829450
Employing Multimodal Machine Learning for Stress Detection. PMID:34745514
A multi-scanner neuroimaging data harmonization using RAVEL and ComBat. PMID:34736996
3D convolutional neural networks-based multiclass classification of Alzheimer's and Parkinson's diseases using PET and SPECT neuroimaging modalities. PMID:34725741
Short- and Long-Term Functional Connectivity Differences Associated with Alzheimer's Disease Progression. PMID:34721501
Network-constrained technique to characterize pathology progression rate in Alzheimer's disease. PMID:34704025
Classification of Alzheimer's Disease Using Gaussian-Based Bayesian Parameter Optimization for Deep Convolutional LSTM Network. PMID:34646334
How Selection Over Time Contributes to the Inconsistency of the Association Between Sex/Gender and Cognitive Decline Across Cognitive Aging Cohorts. PMID:34521111
An isotropic EPI database and analytical pipelines for rat brain resting-state fMRI. PMID:34478824
Apolipoprotein E allele 4 effects on Single-Subject Gray Matter Networks in Mild Cognitive Impairment. PMID:34469849
DeepAtrophy: Teaching a neural network to detect progressive changes in longitudinal MRI of the hippocampal region in Alzheimer's disease. PMID:34450261
Examining the Role of the Noradrenergic Locus Coeruleus for Predicting Attention and Brain Maintenance in Healthy Old Age and Disease: An MRI Structural Study for the Alzheimer's Disease Neuroimaging Initiative. PMID:34359997
A single mode of population covariation associates brain networks structure and behavior and predicts individual subjects' age. PMID:34354185
Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer's disease in a cross-sectional multi-cohort study. PMID:34344910
Correlation between Alzheimer's disease and type 2 diabetes using non-negative matrix factorization. PMID:34315930
Mild to moderate decrease in eGFR and cognitive decline in older adults. PMID:34289074
Association between Alzheimer's disease genes and trajectories of cognitive function decline in Han Chinese in Taiwan. PMID:34214049
Iranian Brain Imaging Database: A Neuropsychiatric Database of Healthy Brain. PMID:33995934
Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease. PMID:33971669
CLEP: A Hybrid Data- and Knowledge- Driven Framework for Generating Patient Representations. PMID:33964127
Early diagnosis of Alzheimer's disease on ADNI data using novel longitudinal score based on functional principal component analysis. PMID:33898638
Correlation of [18F]florbetaben textural features and age of onset of Alzheimer's disease: a principal components analysis approach. PMID:33881633
PDKit: A data science toolkit for the digital assessment of Parkinson's Disease. PMID:33711008
Quantity and quality: Normative open-access neuroimaging databases. PMID:33705468
Single-cell transcriptomics analysis of mild cognitive impairment in World Trade Center disaster responders. PMID:33665344
Multimodal deep learning models for early detection of Alzheimer's disease stage. PMID:33547343
TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans. PMID:33517326
Feasibility and validation of a web-based platform for the self-administered patient collection of demographics, health status, anxiety, depression, and cognition in community dwelling elderly. PMID:33465108
Molecular Imaging Approaches in Dementia. PMID:33464184
Apolipoprotein E4 effects on topological brain network organization in mild cognitive impairment. PMID:33436948
Shared Blood Transcriptomic Signatures between Alzheimer's Disease and Diabetes Mellitus. PMID:33406707
Evaluating the Alzheimer's disease data landscape. PMID:33344750
A prospective cohort study of prodromal Alzheimer's disease: Prospective Imaging Study of Ageing: Genes, Brain and Behaviour (PISA). PMID:33341723
A Paradigm for Longitudinal Complex Network Analysis over Patient Cohorts in Neuroscience. PMID:33312566
A hitchhiker's guide to working with large, open-source neuroimaging datasets. PMID:33288916
ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset. PMID:33285634
Working Memory Decline in Alzheimer's Disease Is Detected by Complexity Analysis of Multimodal EEG-fNIRS. PMID:33279924
Complexity of Frontal Cortex fNIRS Can Support Alzheimer Disease Diagnosis in Memory and Visuo-Spatial Tests. PMID:33266742
Development of an Al-Based Web Diagnostic System for Phenotyping Psychiatric Disorders. PMID:33250789
Alzheimer's Disease Detection Through Whole-Brain 3D-CNN MRI. PMID:33195111
New acquisition techniques and their prospects for the achievable resolution of fMRI. PMID:33130229
High pulse pressure is a risk factor for prodromal Alzheimer's disease: a longitudinal study. PMID:32960784
Data Augmentation Based on Substituting Regional MRIs Volume Scores. PMID:32924031
Phosphodiesterase 4D Gene Modifies the Functional Network of Patients With Mild Cognitive Impairment and Alzheimer's Disease. PMID:32849849
Digital Biomarkers for the Early Detection of Mild Cognitive Impairment: Artificial Intelligence Meets Virtual Reality. PMID:32848660
Differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostics of dementia - lessons for translation into clinical practice. PMID:32843907
Scattering Angle Resolved Optical Coherence Tomography Detects Early Changes in 3xTg Alzheimer's Disease Mouse Model. PMID:32821490
Intensity warping for multisite MRI harmonization. PMID:32798678
MicroRNA-138 promotes neuroblastoma SH-SY5Y cell apoptosis by directly targeting DEK in Alzheimer's disease cell model. PMID:32736520
Cortical atrophy mediates the accumulating effects of vascular risk factors on cognitive decline in the Alzheimer's disease spectrum. PMID:32726298
Cortical surface registration using unsupervised learning. PMID:32702486
Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias. PMID:32582013
Genetic architecture of Alzheimer's disease. PMID:32565066
FastSurfer - A fast and accurate deep learning based neuroimaging pipeline. PMID:32526386
Quantifying uncertainty in brain-predicted age using scalar-on-image quantile regression. PMID:32502669
Most Common Publication Types of Neuroimaging Literature: Papers With High Levels of Evidence Are on the Rise. PMID:32410971
The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study. PMID:32375872
The open EEGLAB portal Interface: High-Performance computing with EEGLAB. PMID:32289453
Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration. PMID:32203580
Chemical and photonic interactions in vitro and in vivo between fluorescent tracer and nanoparticle-based scavenger for enhanced molecular imaging. PMID:32159145
Prediction of Alzheimer's disease using blood gene expression data. PMID:32103140
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. PMID:32094485
Preparing Medical Imaging Data for Machine Learning. PMID:32068507
Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease. PMID:31915256
Educational fMRI: From the Lab to the Classroom. PMID:31866920
Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis. PMID:31827004
The Consortium for the early identification of Alzheimer's disease-Quebec (CIMA-Q). PMID:31788534
Mining multi-site clinical data to develop machine learning MRI biomarkers: application to neonatal hypoxic ischemic encephalopathy. PMID:31752923
FMEM: Functional Mixed Effects Models for Longitudinal Functional Responses. PMID:31745381
Performance of five automated white matter hyperintensity segmentation methods in a multicenter dataset. PMID:31727919
Gene Expressions, Hippocampal Volume Loss, and MMSE Scores in Computation of Progression and Pharmacologic Therapy Effects for Alzheimer's Disease. PMID:31722481
Supervised machine learning for diagnostic classification from large-scale neuroimaging datasets. PMID:31691160
Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease. PMID:31641104
A multipredictor model to predict the conversion of mild cognitive impairment to Alzheimer's disease by using a predictive nomogram. PMID:31634898
Machine learning for comprehensive forecasting of Alzheimer's Disease progression. PMID:31541187
Identifying and ranking potential driver genes of Alzheimer's disease using multiview evidence aggregation. PMID:31510680
ReAl-LiFE: Accelerating the Discovery of Individualized Brain Connectomes on GPUs. PMID:31355051
Identifying Imaging Markers for Predicting Cognitive Assessments Using Wasserstein Distances Based Matrix Regression. PMID:31354405
Dilated Saliency U-Net for White Matter Hyperintensities Segmentation Using Irregularity Age Map. PMID:31316369
Determining clinically meaningful decline in preclinical Alzheimer disease. PMID:31289148
Longitudinal cognitive decline in mild cognitive impairment subjects with early amyloid-β neocortical deposition. PMID:31264171
Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition. PMID:31199530
Subtypes of Alzheimer's Disease Display Distinct Network Abnormalities Extending Beyond Their Pattern of Brain Atrophy. PMID:31191430
Effects of Brain Parcellation on the Characterization of Topological Deterioration in Alzheimer's Disease. PMID:31164815
Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography. PMID:31159754
TREML2 Mutation Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration. PMID:31156362
Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. PMID:31150956
Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI. PMID:31104279
Long-Term Storage Effects on Stability of Aβ1-40, Aβ1-42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays. PMID:31043966
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease. PMID:31006066
Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions. PMID:30872992
Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease. PMID:30863455
Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3. PMID:30837858
Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease. PMID:30833374
Constrained instruments and their application to Mendelian randomization with pleiotropy. PMID:30635941
Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease: a feature selection ensemble combining stability and predictability. PMID:30567554
Computational neuroscience and neuroinformatics: Recent progress and resources. PMID:30541962
Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer's disease. PMID:30511118
Amnestic mild cognitive impairment individuals with dissimilar pathologic origins show common regional vulnerability in the default mode network. PMID:30511009
Toward Exosome-Based Neuronal Diagnostic Devices. PMID:30501125
Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers. PMID:30456290
Quantitative assessment of field strength, total intracranial volume, sex, and age effects on the goodness of harmonization for volumetric analysis on the ADNI database. PMID:30431208
BIOMARKER CHANGE-POINT ESTIMATION WITH RIGHT CENSORING IN LONGITUDINAL STUDIES. PMID:30271520
The joint lasso: high-dimensional regression for group structured data. PMID:30192903
Transfer learning by feature-space transformation: A method for Hippocampus segmentation across scanners. PMID:30128285
Data management and sharing in neuroimaging: Practices and perceptions of MRI researchers. PMID:30011302
An efficient algorithm for estimating brain covariance networks. PMID:30001336
Semi-Supervised Discriminative Classification Robust to Sample-Outliers and Feature-Noises. PMID:29994560
Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data. PMID:29988624
Longitudinal Alzheimer's Degeneration Reflects the Spatial Topography of Cholinergic Basal Forebrain Projections. PMID:29972789
Broadening the scope of epidemiologic dementia research. PMID:29951923
Patient Similarity Networks for Precision Medicine. PMID:29860027
The vast potential and bright future of neuroimaging. PMID:29848016
Cognitive Assessment Prediction in Alzheimer's Disease by Multi-Layer Multi-Target Regression. PMID:29802511
A computational framework for the detection of subcortical brain dysmaturation in neonatal MRI using 3D Convolutional Neural Networks. PMID:29793060
Comparison of Cortical and Subcortical Measurements in Normal Older Adults across Databases and Software Packages. PMID:29756095
Metabolic Syndrome and Neurocognition Among Diverse Middle-Aged and Older Hispanics/Latinos: HCHS/SOL Results. PMID:29716895
Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI). PMID:29694964
Are methodological quality and completeness of reporting associated with citation-based measures of publication impact? A secondary analysis of a systematic review of dementia biomarker studies. PMID:29572396
Mitochondria and Alzheimer's Disease: the Role of Mitochondrial Genetic Variation. PMID:29564191
Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease. PMID:29266591
The past, present, and future of disease-modifying therapies for Alzheimer's disease. PMID:29225305
Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset. PMID:29191870
Spatiotemporal Distribution of β-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities. PMID:29146694
Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease. PMID:29134771
Multivariate association between single-nucleotide polymorphisms in Alzgene linkage regions and structural changes in the brain: discovery, refinement and validation. PMID:29091582
An Enhanced Platform to Analyse Low-Affinity Amyloid β Protein by Integration of Electrical Detection and Preconcentrator. PMID:29084978
The prevalence and biomarkers' characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database. PMID:29067322
Has molecular imaging delivered to drug development? PMID:29038381
Fully Bayesian spectral methods for imaging data. PMID:28960245
Physical Activity in Preventing Alzheimer's Disease and Cognitive Decline: A Narrative Review. PMID:28940148
Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid. PMID:28879083
Advances in Studying Brain Morphology: The Benefits of Open-Access Data. PMID:28824407
Feature selective temporal prediction of Alzheimer's disease progression using hippocampus surface morphometry. PMID:28729939
Four Decades of Research in Alzheimer's Disease (1975-2014): A Bibliometric and Scientometric Analysis. PMID:28671119
Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. PMID:28644039
Does the diurnal cycle of cortisol explain the relationship between physical performance and cognitive function in older adults? PMID:28515793
The changing prevalence and incidence of dementia over time - current evidence. PMID:28497805
Tau oligomers in cerebrospinal fluid in Alzheimer's disease. PMID:28382304
Hippocampus Segmentation Based on Local Linear Mapping. PMID:28368016
Adding Recognition Discriminability Index to the Delayed Recall Is Useful to Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative. PMID:28344552
Your algorithm might think the hippocampus grows in Alzheimer's disease: Caveats of longitudinal automated hippocampal volumetry. PMID:28295799
Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns. PMID:28276464
Support Vector Hazards Machine: A Counting Process Framework for Learning Risk Scores for Censored Outcomes. PMID:28066157
Early Prediction of Alzheimer's Disease Using Null Longitudinal Model-Based Classifiers. PMID:28045907
Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study. PMID:27907080
A profile of The Clinical Course of Cognition and Comorbidity in Mild Cognitive Impairment and Dementia Study (The 4C study): two complementary longitudinal, clinical cohorts in the Netherlands. PMID:27884130
A Stereotactic Probabilistic Atlas for the Major Cerebral Arteries. PMID:27873151
Alzheimer's disease severity, objectively determined and measured. PMID:27830173
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology. PMID:27811848
Robustness of Automated Methods for Brain Volume Measurements across Different MRI Field Strengths. PMID:27798694
The preprocessed connectomes project repository of manually corrected skull-stripped T1-weighted anatomical MRI data. PMID:27782853
Automated identification of dementia using medical imaging: a survey from a pattern classification perspective. PMID:27747596
Phantom criteria for qualification of brain FDG and amyloid PET across different cameras. PMID:27709546
Basic MR sequence parameters systematically bias automated brain volume estimation. PMID:27623782
Data Citation in Neuroimaging: Proposed Best Practices for Data Identification and Attribution. PMID:27570508
Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment. PMID:27567827
Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers. PMID:27472882
A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer's Disease. PMID:27462267
The neurobiology of addiction: the perspective from magnetic resonance imaging present and future. PMID:27452960
Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease. PMID:27432800
From computer-assisted intervention research to clinical impact: The need for a holistic approach. PMID:27425646
Personal Journal Keeping and Linguistic Complexity Predict Late-Life Dementia Risk: The Cache County Journal Pilot Study. PMID:27402137
Changes in the Chemical Barrier Composition of Tears in Alzheimer's Disease Reveal Potential Tear Diagnostic Biomarkers. PMID:27327445
Composite large margin classifiers with latent subclasses for heterogeneous biomedical data. PMID:27326311
The Evolution of Genetics: Alzheimer's and Parkinson's Diseases. PMID:27311081
Inter-site and inter-scanner diffusion MRI data harmonization. PMID:27138209
The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. PMID:27103524
A Review on the Bioinformatics Tools for Neuroimaging. PMID:27006633
CNR improvement of MP2RAGE from slice encoding directional acceleration. PMID:26979541
The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume. PMID:26973105
Translational Meta-analytical Methods to Localize the Regulatory Patterns of Neurological Disorders in the Human Brain. PMID:26958307
Integrating 400 million variants from 80,000 human samples with extensive annotations: towards a knowledge base to analyze disease cohorts. PMID:26746786
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. PMID:26738751
Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders. PMID:26690135
A Federated Network for Translational Cancer Research Using Clinical Data and Biospecimens. PMID:26670560
The Impact of UNC5C Genetic Variations on Neuroimaging in Alzheimer's Disease. PMID:26660111
Automatic labeling of cerebral arteries in magnetic resonance angiography. PMID:26646523
Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition. PMID:26560730
The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects. PMID:26440606
HERITABILITY OF BRAIN NETWORK TOPOLOGY IN 853 TWINS AND SIBLINGS. PMID:26413204
The Function Biomedical Informatics Research Network Data Repository. PMID:26364863
Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum. PMID:26298664
Relevant feature set estimation with a knock-out strategy and random forests. PMID:26272728
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. PMID:26250565
Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia. PMID:26238228
Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution. PMID:26228889
Functional Nonlinear Mixed Effects Models for Longitudinal Image Data. PMID:26213453
The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding. PMID:26194315
Estimating anatomical trajectories with Bayesian mixed-effects modeling. PMID:26190405
How Can We Predict Treatment Outcome for Depression? PMID:26137527
REGULARIZED 3D FUNCTIONAL REGRESSION FOR BRAIN IMAGE DATA VIA HAAR WAVELETS. PMID:26082826
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. PMID:26073027
The PLORAS Database: A data repository for Predicting Language Outcome and Recovery After Stroke. PMID:25882753
Design, implementation and operation of a multimodality research imaging informatics repository. PMID:25870760
CranialCloud: a cloud-based architecture to support trans-institutional collaborative efforts in neurodegenerative disorders. PMID:25861055
The future of human cerebral cartography: a novel approach. PMID:25823868
The rise of large-scale imaging studies in psychiatry. PMID:25793106
Genetics and brain morphology. PMID:25773500
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. PMID:25693589
Automatic analysis (aa): efficient neuroimaging workflows and parallel processing using Matlab and XML. PMID:25642185
Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease. PMID:25633676
View-centralized multi-atlas classification for Alzheimer's disease diagnosis. PMID:25624081
Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer's Disease Neuroimaging Initiative. PMID:25614473
Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort. PMID:25547651
Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease. PMID:25486118
Recollection, not familiarity, decreases in healthy ageing: Converging evidence from four estimation methods. PMID:25485974
Imago Mundi, Imago AD, Imago ADNI. PMID:25478022
Eigenanatomy: sparse dimensionality reduction for multi-modal medical image analysis. PMID:25448483
Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative. PMID:25444607
TRACTOGRAPHY DENSITY AND NETWORK MEASURES IN ALZHEIMER'S DISEASE. PMID:25404994
Mapping ventricular expansion onto cortical gray matter in older adults. PMID:25311280
Q-MKL: Matrix-induced Regularization in Multi-Kernel Learning with Applications to Neuroimaging. PMID:25309107
Sparse Multi-Task Regression and Feature Selection to Identify Brain Imaging Predictors for Memory Performance. PMID:25283084
Brain connectivity and novel network measures for Alzheimer's disease classification. PMID:25264345
Empowering imaging biomarkers of Alzheimer's disease. PMID:25260848
High-Dimensional Medial Lobe Morphometry: An Automated MRI Biomarker for the New AD Diagnostic Criteria. PMID:25254139
Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis. PMID:25194437
Decoupling function and anatomy in atlases of functional connectivity patterns: language mapping in tumor patients. PMID:25172207
Longitudinal analysis is more powerful than cross-sectional analysis in detecting genetic association with neuroimaging phenotypes. PMID:25098835
Evaluating the Predictive Power of Multivariate Tensor-based Morphometry in Alzheimers Disease Progression via Convex Fused Sparse Group Lasso. PMID:25076826
FLOW-BASED NETWORK MEASURES OF BRAIN CONNECTIVITY IN ALZHEIMER'S DISEASE. PMID:25067993
History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress. PMID:25037769
Association of fish oil supplement use with preservation of brain volume and cognitive function. PMID:24954371
Robust T1-weighted structural brain imaging and morphometry at 7T using MP2RAGE. PMID:24932514
High-throughput neuroimaging-genetics computational infrastructure. PMID:24795619
Individualized Gaussian process-based prediction and detection of local and global gray matter abnormalities in elderly subjects. PMID:24742919
Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease. PMID:24628925
Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study. PMID:24453132
Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data. PMID:24448547
High-throughput neuro-imaging informatics. PMID:24381556
Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. PMID:24179750
Analysis of sampling techniques for imbalanced data: An n = 648 ADNI study. PMID:24176869
Reply: To PMID 22976235. PMID:24151644
Structural covariance of the default network in healthy and pathological aging. PMID:24048852
How to produce personality neuroscience research with high statistical power and low additional cost. PMID:23982973
The perfect neuroimaging-genetics-computation storm: collision of petabytes of data, millions of hardware devices and thousands of software tools. PMID:23975276
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. PMID:23932184
Neuroinformatics Database (NiDB)--a modular, portable database for the storage, analysis, and sharing of neuroimaging data. PMID:23912507
Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment. PMID:23894356
Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. PMID:23883936
ATP5H/KCTD2 locus is associated with Alzheimer's disease risk. PMID:23857120
An exploration of the potential mechanisms and translational potential of five medicinal plants for applications in Alzheimer's disease. PMID:23844333
Neuroimaging of dementia in 2013: what radiologists need to know. PMID:23839168
MilxXplore: a web-based system to explore large imaging datasets. PMID:23775173
The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia. PMID:23760817
Multivariate decoding of brain images using ordinal regression. PMID:23684876
Local mechanical properties of white matter structures in the human brain. PMID:23644001
Are apathy and depression independently associated with longitudinal trajectories of cortical atrophy in mild cognitive impairment? PMID:23636003
Clinical applications of the functional connectome. PMID:23631991
Increased CNV-region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample. PMID:23583670
Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease. PMID:23482655
Hierarchical fusion of features and classifier decisions for Alzheimer's disease diagnosis. PMID:23417832
Adaptive image segmentation for robust measurement of longitudinal brain tissue change. PMID:23367130
Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease. PMID:23365250
Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features. PMID:23296188
Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease. PMID:23251365
Measuring abnormal brains: building normative rules in neuroimaging using one-class support vector machines. PMID:23248579
Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly. PMID:23238164
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. PMID:23179062
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. PMID:23153970
Developing dementia prevention trials: baseline report of the Home-Based Assessment study. PMID:23151596
Standardization of analysis sets for reporting results from ADNI MRI data. PMID:23110865
Greater regional brain atrophy rate in healthy elderly subjects with a history of cigarette smoking. PMID:23102121
Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. PMID:23102118
Trends in the prevalence of dementia in Japan. PMID:23091769
The NKI-Rockland Sample: A Model for Accelerating the Pace of Discovery Science in Psychiatry. PMID:23087608
Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease. PMID:23070747
OPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASE. PMID:22973426
From phenotype to genotype: an association study of longitudinal phenotypic markers to Alzheimer's disease relevant SNPs. PMID:22962490
System for integrated neuroimaging analysis and processing of structure. PMID:22932976
Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. PMID:22840744
Plasma biomarkers of depressive symptoms in older adults. PMID:22832727
Confirmatory factor analysis of the ADNI Neuropsychological Battery. PMID:22777078
Cortical signatures of cognition and their relationship to Alzheimer's disease. PMID:22718430
Mild cognitive impairment: statistical models of transition using longitudinal clinical data. PMID:22536535
Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies. PMID:22535791
Ligand binding assays in the 21st century laboratory-a call for change. PMID:22476913
Structural brain alterations before mild cognitive impairment in ADNI: validation of volume loss in a predefined antero-temporal region. PMID:22460332
Do brain image databanks support understanding of normal ageing brain structure? A systematic review. PMID:22354559
Ensemble sparse classification of Alzheimer's disease. PMID:22270352
Impact of Markov Random Field optimizer on MRI-based tissue segmentation in the aging brain. PMID:22256150
Plasma biomarkers of brain atrophy in Alzheimer's disease. PMID:22205954
Brain imaging in the study of Alzheimer's disease. PMID:22173295
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. PMID:22047634
High dimensional classification of structural MRI Alzheimer's disease data based on large scale regularization. PMID:22016732
Power calculations for clinical trials in Alzheimer's disease. PMID:21971476
DTI analyses and clinical applications in Alzheimer's disease. PMID:21971468
Chromatin plasticity and the pathogenesis of Huntington disease. PMID:21969556
Multimodal MRI neuroimaging biomarkers for cognitive normal adults, amnestic mild cognitive impairment, and Alzheimer's disease. PMID:21949904
SUMA. PMID:21945692
A blood-based algorithm for the detection of Alzheimer's disease. PMID:21865746
Induction of pluripotent stem cells from autopsy donor-derived somatic cells. PMID:21839145
Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI. PMID:21830259
Emerging imaging tools for use with traumatic brain injury research. PMID:21787167
Morphological Factor Estimation via High-Dimensional Reduction: Prediction of MCI Conversion to Probable AD. PMID:21755033
Staging Alzheimer's disease progression with multimodality neuroimaging. PMID:21718750
The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease. PMID:21627779
Hippocampal volume is related to body mass index in Alzheimer's disease. PMID:21539003
Topology-based kernels with application to inference problems in Alzheimer's disease. PMID:21536520
Homocysteine effects on brain volumes mapped in 732 elderly individuals. PMID:21512418
Surface-based TBM boosts power to detect disease effects on the brain: an N=804 ADNI study. PMID:21440071
Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. PMID:21220675
Statistical analysis of relative pose information of subcortical nuclei: application on ADNI data. PMID:21216295
Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. PMID:21146621
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease. PMID:21116278
Quantitative structural MRI for early detection of Alzheimer's disease. PMID:20977326
Neuroimaging study designs, computational analyses and data provenance using the LONI pipeline. PMID:20927408
Cognitive neuroscience 2.0: building a cumulative science of human brain function. PMID:20884276
Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directions. PMID:20856693
Nonlinear time course of brain volume loss in cognitively normal and impaired elders. PMID:20855131
Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment. PMID:20813341
Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials. PMID:20813339
Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. PMID:20678521
Neuroimaging in the clinical diagnosis of dementia: observations from a memory disorders clinic. PMID:20670380
Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics. PMID:20658795
Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. PMID:20620666
Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. PMID:20620664
Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline. PMID:20620663
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. PMID:20592748
Pilot study to show the feasibility of a multicenter trial of home-based assessment of people over 75 years old. PMID:20592583
Obesity is linked with lower brain volume in 700 AD and MCI patients. PMID:20570405
Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease. PMID:20558388
Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. PMID:20542598
Reducing modeling error of graphical methods for estimating volume of distribution measurements in PIB-PET study. PMID:20493196
The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. PMID:20451874
The Alzheimer's disease neuroimaging initiative: progress report and future plans. PMID:20451868
Whole brain quantitative T2 MRI across multiple scanners with dual echo FSE: applications to AD, MCI, and normal aging. PMID:20441797
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. PMID:20404173
Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. PMID:20383319
Cerebrospinal fluid biomarkers of Alzheimer's disease. PMID:20361010
Multivariate models of inter-subject anatomical variability. PMID:20347998
Study design considerations: conducting global clinical trials in early Alzheimer's disease. PMID:20306004
Design of comprehensive Alzheimer's disease centers to address unmet national needs. PMID:20298979
Predicting language outcome and recovery after stroke: the PLORAS system. PMID:20212513
Tensor-based morphometry with stationary velocity field diffeomorphic registration: application to ADNI. PMID:20211269
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. PMID:20202480
Visualization of image data from cells to organisms. PMID:20195255
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease. PMID:20182051
Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. PMID:20139010
Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative. PMID:20110588
Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder. PMID:20104401
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. PMID:20100581
Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. PMID:20083211
APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. PMID:20065135
Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: an illustration in ADNI 3 T MRI data. PMID:20005963
Open access series of imaging studies: longitudinal MRI data in nondemented and demented older adults. PMID:19929323
Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD. PMID:19847043
Structural neuroimaging in the detection and prognosis of pre-clinical and early AD. PMID:19847040
Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry. PMID:19780044
Targeting Abeta and tau in Alzheimer's disease, an early interim report. PMID:19716367
Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR. PMID:19694267
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. PMID:19689234
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PMID:19668339
Parallel imaging: is GRAPPA a useful acquisition tool for MR imaging intended for volumetric brain analysis? PMID:19650898
Efficient, Distributed and Interactive Neuroimaging Data Analysis Using the LONI Pipeline. PMID:19649168
Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. PMID:19615450
The Memory and Aging Telephone Screen: development and preliminary validation. PMID:19595923
Challenges to demonstrating disease-modifying effects in Alzheimer's disease clinical trials. PMID:19595897
Multisite neuroimaging trials. PMID:19506479
Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset. PMID:19481161
High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. PMID:19474571
Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. PMID:19439419
Musings of a post-stimulus mind.. PMID:19434520
Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease. PMID:19353345
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). PMID:19349228
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States. PMID:19328440
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. PMID:19296504
Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. PMID:19280688
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. PMID:19280686
Analytic methods for factors, dimensions and endpoints in clinical trials for Alzheimer's disease. PMID:19262962
In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease. PMID:19252794
Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. PMID:19236926
K-Bayes reconstruction for perfusion MRI. I: concepts and application. PMID:19205805
Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. PMID:19201945
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. PMID:19172649
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. PMID:19041724
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. PMID:18691658
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. PMID:18675918
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. PMID:18631976
Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease. PMID:18543125
Provenance in neuroimaging. PMID:18519166
Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. PMID:18395760
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. PMID:18378167
Expanding ventricles may detect preclinical Alzheimer disease. PMID:18332339
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. PMID:18302232
Current and future uses of neuroimaging for cognitively impaired patients. PMID:18207114
An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases. PMID:17938898
Alzheimer 100--highlights in the history of Alzheimer research. PMID:17039299
Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. PMID:16860440
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. PMID:16480900
The Alzheimer's disease neuroimaging initiative PubMed citations: 358.

358 articles citing: The Alzheimer's disease neuroimaging initiative

Neuropsychology and MRI correlates of neurodegeneration in SPG11 hereditary spastic paraplegia. PMID:35906604
Thalamic volumetric abnormalities in type 1 diabetes mellitus and 'peripheral' neuropathy. PMID:35906253
Deep learning for fast low-field MRI acquisitions. PMID:35794175
Editorial: Modern Statistical Learning Strategies in Imaging Genetics. PMID:35784848
A Robust Modular Automated Neuroimaging Pipeline for Model Inputs to TheVirtualBrain. PMID:35784190
A Reparametrized CNN Model to Distinguish Alzheimer's Disease Applying Multiple Morphological Metrics and Deep Semantic Features From Structural MRI. PMID:35721011
A multi-site, multi-participant magnetoencephalography resting-state dataset to study dementia: The BioFIND dataset. PMID:35660461
A penalized linear mixed model with generalized method of moments for prediction analysis on high-dimensional multi-omics data. PMID:35649346
Disentangling Alzheimer's disease neurodegeneration from typical brain ageing using machine learning. PMID:35611306
Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging. PMID:35606419
The Current Landscape of Prevention Trials in Dementia. PMID:35587314
Imaging Genetic Based Mediation Analysis for Human Cognition. PMID:35573299
Analyzing Hierarchical Multi-View MRI Data With StaPLR: An Application to Alzheimer's Disease Classification. PMID:35546881
Network-wise concordance of multimodal neuroimaging features across the Alzheimer's disease continuum. PMID:35496375
Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume. PMID:35445885
A high-generalizability machine learning framework for predicting the progression of Alzheimer's disease using limited data. PMID:35414651
Normative Data for Brainstem Structures, the Midbrain-to-Pons Ratio, and the Magnetic Resonance Parkinsonism Index. PMID:35393362
Impact of defacing on automated brain atrophy estimation. PMID:35348936
Cortical Surface Shape Analysis Based on Alexandrov Polyhedra. PMID:35291440
Learning stochastic object models from medical imaging measurements by use of advanced ambient generative adversarial networks. PMID:35229009
Semantic Integration of Multi-Modal Data and Derived Neuroimaging Results Using the Platform for Imaging in Precision Medicine (PRISM) in the Arkansas Imaging Enterprise System (ARIES). PMID:35224477
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial. PMID:35103388
MEDAS: an open-source platform as a service to help break the walls between medicine and informatics. PMID:35068703
The North American Registry for Care and Research in Multiple Sclerosis (NARCRMS). PMID:35035298
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives. PMID:35005206
Predicting Tau Accumulation in Cerebral Cortex with Multivariate MRI Morphometry Measurements, Sparse Coding, and Correntropy. PMID:34961803
Mitigating site effects in covariance for machine learning in neuroimaging data. PMID:34904312
Artificial intelligence with deep learning in nuclear medicine and radiology. PMID:34897550
Examining the Role of the Noradrenergic Locus Coeruleus for Predicting Attention and Brain Maintenance in Healthy Old Age and Disease: An MRI Structural Study for the Alzheimer's Disease Neuroimaging Initiative. PMID:34359997
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET. PMID:34328531
Convolutional Bayesian Models for Anatomical Landmarking on Multi-Dimensional Shapes. PMID:34291235
Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness. PMID:34236619
Tetrahedral spectral feature-Based bayesian manifold learning for grey matter morphometry: Findings from the Alzheimer's disease neuroimaging initiative. PMID:34214958
Deep learning-based amyloid PET positivity classification model in the Alzheimer's disease continuum by using 2-[18F]FDG PET. PMID:34114091
Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases. PMID:34062930
Tackling Ordinal Regression Problem for Heterogeneous Data: Sparse and Deep Multi-Task Learning Approaches. PMID:34054330
Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study. PMID:34043628
Cognitive dedifferentiation as a function of cognitive impairment in the ADNI and MemClin cohorts. PMID:34038387
Surface Foliation Based Brain Morphometry Analysis. PMID:33982034
Morphometric Gaussian Process for Landmarking on Grey Matter Tetrahedral Models. PMID:33981127
Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease. PMID:33971669
Multi-Layer Picture of Neurodegenerative Diseases: Lessons from the Use of Big Data through Artificial Intelligence. PMID:33917161
Early diagnosis of Alzheimer's disease on ADNI data using novel longitudinal score based on functional principal component analysis. PMID:33898638
Multi-Resemblance Multi-Target Low-Rank Coding for Prediction of Cognitive Decline With Longitudinal Brain Images. PMID:33798076
Brain/MINDS beyond human brain MRI project: A protocol for multi-level harmonization across brain disorders throughout the lifespan. PMID:33741307
Multiple Subtypes of Alzheimer's Disease Base on Brain Atrophy Pattern. PMID:33672406
Genome-wide haplotype association study in imaging genetics using whole-brain sulcal openings of 16,304 UK Biobank subjects. PMID:33664500
A Systems Biology Approach for Hypothesizing the Effect of Genetic Variants on Neuroimaging Features in Alzheimer's Disease. PMID:33554913
A Bayesian linear mixed model for prediction of complex traits. PMID:33331865
Cellular correlates of cortical thinning throughout the lifespan. PMID:33311571
Comparison of subtyping methods for neuroimaging studies in Alzheimer's disease: a call for harmonization. PMID:33305264
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset. PMID:33223526
Developing univariate neurodegeneration biomarkers with low-rank and sparse subspace decomposition. PMID:33166772
Development and Validation of a Deep Learning-Based Automatic Brain Segmentation and Classification Algorithm for Alzheimer Disease Using 3D T1-Weighted Volumetric Images. PMID:33154073
A Survey on Deep Learning for Neuroimaging-Based Brain Disorder Analysis. PMID:33117114
Nonlinear interaction between APOE ε4 allele load and age in the hippocampal surface of cognitively intact individuals. PMID:33017488
Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study. PMID:32925067
Affective Neuropsychiatric Symptoms as Early Signs of Dementia Risk in Older Adults. PMID:32925031
Improving in vivo human cerebral cortical surface reconstruction using data-driven super-resolution. PMID:32887984
A probabilistic atlas of locus coeruleus pathways to transentorhinal cortex for connectome imaging in Alzheimer's disease. PMID:32861791
Diagnosis of early Alzheimer's disease based on dynamic high order networks. PMID:32789620
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodology. PMID:32775597
The correlation of everyday cognition test scores and the progression of Alzheimer's disease: a data analytics study. PMID:32765845
Comparison and validation of seven white matter hyperintensities segmentation software in elderly patients. PMID:32739882
Groupwise track filtering via iterative message passing and pruning. PMID:32673747
Identifying diagnosis-specific genotype-phenotype associations via joint multitask sparse canonical correlation analysis and classification. PMID:32657360
Neurological update: neuroimaging in dementia. PMID:32638104
Data sharing and privacy issues in neuroimaging research: Opportunities, obstacles, challenges, and monsters under the bed. PMID:32621651
ENIGMA-anxiety working group: Rationale for and organization of large-scale neuroimaging studies of anxiety disorders. PMID:32618421
Identification of functionally connected multi-omic biomarkers for Alzheimer's disease using modularity-constrained Lasso. PMID:32555747
On the horizon-the value and promise of the global pipeline of Alzheimer's disease therapeutics. PMID:32405530
Brain Morphometry Estimation: From Hours to Seconds Using Deep Learning. PMID:32322235
Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study. PMID:32310181
Toward Community-Driven Big Open Brain Science: Open Big Data and Tools for Structure, Function, and Genetics. PMID:32283996
Predicting conversion to Alzheimer's disease among individual high-risk patients using the Characterizing AD Risk Events index model. PMID:32243064
The MemClin project: a prospective multi memory clinics study targeting early stages of cognitive impairment. PMID:32138686
Data science in neurodegenerative disease: its capabilities, limitations, and perspectives. PMID:32073441
Genome-wide association study of white matter hyperintensity volume in elderly persons without dementia. PMID:32062564
Challenges of Integrative Disease Modeling in Alzheimer's Disease. PMID:31993440
Informant Reporting in Mild Cognitive Impairment: Sources of Discrepancy on the Functional Activities Questionnaire. PMID:31964443
Explainable Anatomical Shape Analysis Through Deep Hierarchical Generative Models. PMID:31944949
Deterioration from healthy to mild cognitive impairment and Alzheimer's disease mirrored in corresponding loss of centrality in directed brain networks. PMID:31792630
Knowing What You Know in Brain Segmentation Using Bayesian Deep Neural Networks. PMID:31749693
Practical algorithms for amyloid β probability in subjective or mild cognitive impairment. PMID:31700988
Multi-Task Sparse Canonical Correlation Analysis with Application to Multi-Modal Brain Imaging Genetics. PMID:31634139
Accurate and robust segmentation of neuroanatomy in T1-weighted MRI by combining spatial priors with deep convolutional neural networks. PMID:31633863
Alternative splicing in Alzheimer's disease. PMID:31583531
Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study. PMID:31535240
Identifying progressive imaging genetic patterns via multi-task sparse canonical correlation analysis: a longitudinal study of the ADNI cohort. PMID:31510645
Image processing and analysis methods for the Adolescent Brain Cognitive Development Study. PMID:31415884
Toward a Better Estimation of Functional Brain Network for Mild Cognitive Impairment Identification: A Transfer Learning View. PMID:31403449
Systematic Differences Between Perceptually Relevant Image Statistics of Brain MRI and Natural Images. PMID:31293409
PSACNN: Pulse sequence adaptive fast whole brain segmentation. PMID:31129303
The utility of multivariate outlier detection techniques for data quality evaluation in large studies: an application within the ONDRI project. PMID:31092212
Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative. PMID:30958366
Patch-based Mapping of Transentorhinal Cortex with a Distributed Atlas. PMID:30957108
Voxel Deconvolutional Networks for 3D Brain Image Labeling. PMID:30906620
Fast Multi-Task SCCA Learning with Feature Selection for Multi-Modal Brain Imaging Genetics. PMID:30881731
From the Wet Lab to the Web Lab: A Paradigm Shift in Brain Imaging Research. PMID:30881299
Evaluating reinforcement learning agents for anatomical landmark detection. PMID:30784956
Hyperbolic Wasserstein Distance for Shape Indexing. PMID:30763239
Common Variants in PLXNA4 and Correlation to CSF-related Phenotypes in Alzheimer's Disease. PMID:30618575
Iron Dysregulation and Dormant Microbes as Causative Agents for Impaired Blood Rheology and Pathological Clotting in Alzheimer's Type Dementia. PMID:30519157
Unsupervised Manifold Learning Using High-Order Morphological Brain Networks Derived From T1-w MRI for Autism Diagnosis. PMID:30459585
Generation and quality control of lipidomics data for the alzheimer's disease neuroimaging initiative cohort. PMID:30457571
Quantitative assessment of field strength, total intracranial volume, sex, and age effects on the goodness of harmonization for volumetric analysis on the ADNI database. PMID:30431208
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain. PMID:30398430
A structural equation model for imaging genetics using spatial transcriptomics. PMID:30390165
A Tetrahedron-based Heat Flux Signature for Cortical Thickness Morphometry Analysis. PMID:30338317
Voxel-wise deviations from healthy aging for the detection of region-specific atrophy. PMID:30278372
Amyloid Load: A More Sensitive Biomarker for Amyloid Imaging. PMID:30190305
Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer's disease: a longitudinal cohort study. PMID:30153858
Metastable neural dynamics in Alzheimer's disease are disrupted by lesions to the structural connectome. PMID:30130642
Quantitative MRI of Perivascular Spaces at 3T for Early Diagnosis of Mild Cognitive Impairment. PMID:30093484
A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease. PMID:30010762
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. PMID:29980228
An efficient and accurate method for robust inter-dataset brain extraction and comparisons with 9 other methods. PMID:29972616
Predicting Working Memory Capacity in Older Subjects Using Quantitative Electroencephalography. PMID:29969850
The impact of GAB2 genetic variations on cerebrospinal fluid markers in Alzheimer's disease. PMID:29951493
Joint Pairing and Structured Mapping of Convolutional Brain Morphological Multiplexes for Early Dementia Diagnosis. PMID:29926746
The A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment. PMID:29849029
The vast potential and bright future of neuroimaging. PMID:29848016
HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition. PMID:29794829
VariFunNet, an integrated multiscale modeling framework to study the effects of rare non-coding variants in Genome-Wide Association Studies: applied to Alzheimer's Disease. PMID:29692948
Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content. PMID:29679574
Riemannian metric optimization on surfaces (RMOS) for intrinsic brain mapping in the Laplace-Beltrami embedding space. PMID:29574399
Are methodological quality and completeness of reporting associated with citation-based measures of publication impact? A secondary analysis of a systematic review of dementia biomarker studies. PMID:29572396
Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. PMID:29562524
Consensus recommendations on standardized magnetic resonance imaging protocols for multicenter canine brain tumor clinical trials. PMID:29522650
Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states. PMID:29515158
Learning-Based Estimation of Functional Correlation Tensors in White Matter for Early Diagnosis of Mild Cognitive Impairment. PMID:29430573
Validation of prognostic biomarker scores for predicting progression of dementia in patients with amnestic mild cognitive impairment. PMID:29419659
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PMID:29370177
Regional vulnerability in Alzheimer's disease: The role of cell-autonomous and transneuronal processes. PMID:29306583
Assessing robustness of hazard ratio estimates to outcome misclassification in longitudinal panel studies with application to Alzheimer's disease. PMID:29272296
Multivariate regression analysis of structural MRI connectivity matrices in Alzheimer's disease. PMID:29135998
Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative. PMID:29095836
Has molecular imaging delivered to drug development? PMID:29038381
MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis. PMID:29036183
Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers. PMID:29030451
Cross-Sectional Relationships of Physical Activity and Sedentary Behavior With Cognitive Function in Older Adults With Probable Mild Cognitive Impairment. PMID:29029554
Identification of associations between genotypes and longitudinal phenotypes via temporally-constrained group sparse canonical correlation analysis. PMID:28881979
SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts. PMID:28847219
Learning-based structurally-guided construction of resting-state functional correlation tensors. PMID:28729016
Grid-based stochastic search for hierarchical gene-gene interactions in population-based genetic studies of common human diseases. PMID:28572842
Multi-modal classification of neurodegenerative disease by progressive graph-based transductive learning. PMID:28551556
Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study. PMID:28459000
Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications. PMID:28417965
Hippocampus Segmentation Based on Local Linear Mapping. PMID:28368016
Gene- Gene Interaction between PPARG and APOE Gene on Late-Onset Alzheimer's Disease: A Case- Control Study in Chinese Han Population. PMID:28346566
Concatenated Spatially-localized Random Forests for Hippocampus Labeling in Adult and Infant MR Brain Images. PMID:28133417
Early Prediction of Alzheimer's Disease Using Null Longitudinal Model-Based Classifiers. PMID:28045907
Towards a Holistic Cortical Thickness Descriptor: Heat Kernel-Based Grey Matter Morphology Signatures. PMID:28033566
The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. PMID:27931796
CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders. PMID:27890865
Robust skull stripping using multiple MR image contrasts insensitive to pathology. PMID:27864083
Statistical estimation of white matter microstructure from conventional MRI. PMID:27722085
Phantom criteria for qualification of brain FDG and amyloid PET across different cameras. PMID:27709546
Conformal invariants for multiply connected surfaces: Application to landmark curve-based brain morphometry analysis. PMID:27639215
MINC 2.0: A Flexible Format for Multi-Modal Images. PMID:27563289
Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration. PMID:27558378
Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers. PMID:27472882
Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. PMID:27381087
Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates. PMID:27357684
Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness. PMID:27354958
Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia. PMID:27239524
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease. PMID:27231704
Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. PMID:27229352
Impact of SORL1 genetic variations on MRI markers in non-demented elders. PMID:27177090
The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum. PMID:27117083
The traveling heads: multicenter brain imaging at 7 Tesla. PMID:27097904
Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease. PMID:27079753
Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer's Disease. PMID:27056077
Effects of HLA-DRB1/DQB1 Genetic Variants on Neuroimaging in Healthy, Mild Cognitive Impairment, and Alzheimer's Disease Cohorts. PMID:27056075
HLA-A2 Alleles Mediate Alzheimer's Disease by Altering Hippocampal Volume. PMID:26979752
Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. PMID:26950278
Brain structure in autism: a voxel-based morphometry analysis of the Autism Brain Imaging Database Exchange (ABIDE). PMID:26941174
Automatic labeling of MR brain images by hierarchical learning of atlas forests. PMID:26936703
Probabilistic Modeling of Imaging, Genetics and Diagnosis. PMID:26886973
Role of Hybrid Brain Imaging in Neuropsychiatric Disorders. PMID:26854172
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. PMID:26738751
Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders. PMID:26690135
Multi-scale Heat Kernel based Volumetric Morphology Signature. PMID:26550613
Global Data Sharing in Alzheimer Disease Research. PMID:26523713
Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects. PMID:26476234
Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study. PMID:26401773
Spatio-Temporal Regularization for Longitudinal Registration to Subject-Specific 3d Template. PMID:26301716
Mild cognitive impairment and fMRI studies of brain functional connectivity: the state of the art. PMID:26300802
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. PMID:26250565
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. PMID:26194320
Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative. PMID:26194308
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. PMID:26073027
Hot Topics in Research: Preventive Neuroradiology in Brain Aging and Cognitive Decline. PMID:26045577
The Statistical Modeling of Aging and Risk of Transition Project: Data Collection and Harmonization Across 11 Longitudinal Cohort Studies of Aging, Cognition, and Dementia. PMID:25984574
Altered Neural Activity during Semantic Object Memory Retrieval in Amnestic Mild Cognitive Impairment as Measured by Event-Related Potentials. PMID:25835419
Diseased Region Detection of Longitudinal Knee Magnetic Resonance Imaging Data. PMID:25823031
Medical data transformation using rewriting. PMID:25750622
A novel cortical thickness estimation method based on volumetric Laplace-Beltrami operator and heat kernel. PMID:25700360
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset. PMID:25654503
Medical data transformation using rewriting. PMID:25750622
A novel cortical thickness estimation method based on volumetric Laplace-Beltrami operator and heat kernel. PMID:25700360
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset. PMID:25654503
Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer's Disease Neuroimaging Initiative. PMID:25614473
Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease. PMID:25600871
Persistent Reeb Graph Matching for Fast Brain Search. PMID:25594076
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study. PMID:25580592
Posterior brain white matter abnormalities in older adults with probable mild cognitive impairment. PMID:25523313
Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. PMID:25500120
Unbiased approaches to biomarker discovery in neurodegenerative diseases. PMID:25442938
Integration of multiscale dendritic spine structure and function data into systems biology models. PMID:25429262
BrainPrint: identifying subjects by their brain. PMID:25320780
Empowering imaging biomarkers of Alzheimer's disease. PMID:25260848
Studying variability in human brain aging in a population-based German cohort-rationale and design of 1000BRAINS. PMID:25071558
History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress. PMID:25037769
Longitudinal deformation models, spatial regularizations and learning strategies to quantify Alzheimer's disease progression. PMID:24936423
Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative. PMID:24924673
Joint modeling of imaging and genetics. PMID:24684016
Conformal mapping via metric optimization with application for cortical label fusion. PMID:24683973
Fast and accurate modelling of longitudinal and repeated measures neuroimaging data. PMID:24650594
Knowledge-guided robust MRI brain extraction for diverse large-scale neuroimaging studies on humans and non-human primates. PMID:24489639
Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network. PMID:24475827
Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study. PMID:24453132
Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. PMID:24179750
Systematic Redaction for Neuroimage Data. PMID:24179597
Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size. PMID:24077433
Magnetic Resonance Image Example-Based Contrast Synthesis. PMID:24058022
Multi-Source Learning for Joint Analysis of Incomplete Multi-Modality Neuroimaging Data. PMID:24014189
Bi-level multi-source learning for heterogeneous block-wise missing data. PMID:23988272
Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosis. PMID:23982962
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. PMID:23932184
Imaging-based observational databases for clinical problem solving: the role of informatics. PMID:23775172
Automatic hippocampus segmentation of 7.0 Tesla MR images by combining multiple atlases and auto-context models. PMID:23769921
The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia. PMID:23760817
Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study. PMID:23727081
Influence of magnetic field strength and image registration strategy on voxel-based morphometry in a study of Alzheimer's disease. PMID:23723177
Functional anatomy of essential tremor: lessons from neuroimaging. PMID:23620075
Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease. PMID:23482655
Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity. PMID:23471985
Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease. PMID:23405083
Most edges in Markov random fields for white matter hyperintensity segmentation are worthless. PMID:23366478
Reliable identification of deep sulcal pits: the effects of scan session, scanner, and surface extraction tool. PMID:23308272
Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features. PMID:23296188
Unified geometry and topology correction for cortical surface reconstruction with intrinsic reeb analysis. PMID:23285601
Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly. PMID:23182131
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. PMID:23179062
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. PMID:23153970
Greater regional brain atrophy rate in healthy elderly subjects with a history of cigarette smoking. PMID:23102121
Cortical surface reconstruction via unified Reeb analysis of geometric and topological outliers in magnetic resonance images. PMID:23086519
Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease. PMID:23070747
Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning. PMID:23036450
Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. PMID:22954311
Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. PMID:22922821
Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study. PMID:22883691
Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. PMID:22840744
Plasma biomarkers of depressive symptoms in older adults. PMID:22832727
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. PMID:22784036
Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging. PMID:22782510
Predicting brain activity using a Bayesian spatial model. PMID:22743280
Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research. PMID:22720174
Whither the hippocampus? FDG-PET hippocampal hypometabolism in Alzheimer disease revisited. PMID:22700745
Brain structural and functional recovery following initiation of combination antiretroviral therapy. PMID:22692914
Clinical research risk assessment among individuals with mild cognitive impairment. PMID:22549368
Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data. PMID:22498655
Data sharing in neuroimaging research. PMID:22493576
Cross-validation of brain structural biomarkers and cognitive aging in a community-based study. PMID:22420888
Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease. PMID:22414786
Functional connectivity measured with magnetoencephalography identifies persons with HIV disease. PMID:22328062
Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. PMID:22322105
Consistent segmentation using a Rician classifier. PMID:22204754
Diagnostic neuroimaging across diseases. PMID:22094642
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. PMID:22047634
Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease. PMID:22022397
High dimensional classification of structural MRI Alzheimer's disease data based on large scale regularization. PMID:22016732
Instrumental activities of daily living impairment is associated with increased amyloid burden. PMID:21778725
Effects of hardware heterogeneity on the performance of SVM Alzheimer's disease classifier. PMID:21708272
Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. PMID:21646578
The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease. PMID:21627779
Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. PMID:21575871
Hippocampal volume is related to body mass index in Alzheimer's disease. PMID:21539003
Surface-based TBM boosts power to detect disease effects on the brain: an N=804 ADNI study. PMID:21440071
MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers? PMID:21319968
Statistical analysis of relative pose information of subcortical nuclei: application on ADNI data. PMID:21216295
Brain MAPS: an automated, accurate and robust brain extraction technique using a template library. PMID:21195780
Pooled analysis of brain activity in irritable bowel syndrome and controls during rectal balloon distension. PMID:21118328
Multi-parametric neuroimaging reproducibility: a 3-T resource study. PMID:21094686
Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study. PMID:20932310
Mapping anterior temporal lobe language areas with fMRI: a multicenter normative study. PMID:20884358
Sparse bayesian learning for identifying imaging biomarkers in AD prediction. PMID:20879451
Nonlinear time course of brain volume loss in cognitively normal and impaired elders. PMID:20855131
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. PMID:20833446
Characterization of Atrophic Changes in the Cerebral Cortex Using Fractal Dimensional Analysis. PMID:20740072
An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging. PMID:20733305
Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. PMID:20720076
Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease. PMID:20683184
Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics. PMID:20658795
Robust surface reconstruction via Laplace-Beltrami eigen-projection and boundary deformation. PMID:20624704
Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. PMID:20620666
Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. PMID:20620664
Obesity is linked with lower brain volume in 700 AD and MCI patients. PMID:20570405
The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. PMID:20451874
The Alzheimer's disease neuroimaging initiative: progress report and future plans. PMID:20451868
Cortical shape analysis in the Laplace-Beltrami feature space. PMID:20426114
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. PMID:20404173
Blood-based biomarkers of Alzheimer's disease: challenging but feasible. PMID:20387303
Machine-learning techniques for building a diagnostic model for very mild dementia. PMID:20382237
Tensor-based morphometry with stationary velocity field diffeomorphic registration: application to ADNI. PMID:20211269
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. PMID:20202480
Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease. PMID:20182051
Voxelwise genome-wide association study (vGWAS). PMID:20171287
Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. PMID:20139010
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. PMID:20100581
Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. PMID:20034579
Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort. PMID:19913626
Regional impact of field strength on voxel-based morphometry results. PMID:19862698
Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD. PMID:19847043
Structural neuroimaging in the detection and prognosis of pre-clinical and early AD. PMID:19847040
Pooling FMRI data: meta-analysis, mega-analysis and multi-center studies. PMID:19826498
LEAP: learning embeddings for atlas propagation. PMID:19815080
Biological markers of amyloid beta-related mechanisms in Alzheimer's disease. PMID:19815015
Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry. PMID:19780044
Posterior Cingulate and Lateral Parietal Gray Matter Volume in Older Adults with Depressive Symptoms. PMID:19701486
Inverse-consistent surface mapping with Laplace-Beltrami eigen-features. PMID:19694286
Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. PMID:19689234
Update on amyloid imaging: from healthy aging to Alzheimer's disease. PMID:19664363
Parallel imaging: is GRAPPA a useful acquisition tool for MR imaging intended for volumetric brain analysis? PMID:19650898
Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. PMID:19615450
Parametric surface modeling and registration for comparison of manual and automated segmentation of the hippocampus. PMID:19405146
Is it time to re-prioritize neuroimaging databases and digital repositories? PMID:19371790
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. PMID:19280686
Structural MRI biomarkers for preclinical and mild Alzheimer's disease. PMID:19277975
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. PMID:19251758
Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. PMID:19236926
MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. PMID:19233293
K-Bayes reconstruction for perfusion MRI. I: concepts and application. PMID:19205805
Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. PMID:19201945
Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. PMID:19188573
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. PMID:19172649
Functional magnetic resonance imaging (FMRI) in the classroom. PMID:19132618
Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. PMID:19095067
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. PMID:19041724
Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. PMID:18835868
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. PMID:18691658
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. PMID:18675918
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. PMID:18632739
Multi-site voxel-based morphometry: methods and a feasibility demonstration with childhood absence epilepsy. PMID:18585930
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. PMID:18515975
Decisional capacity for research participation in individuals with mild cognitive impairment. PMID:18482298
Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. PMID:18410325
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. PMID:18378167
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. PMID:18302232
Automatic classification of MR scans in Alzheimer's disease. PMID:18202106
Interpreting scan data acquired from multiple scanners: a study with Alzheimer's disease. PMID:18032068
Feasibility of multi-site clinical structural neuroimaging studies of aging using legacy data. PMID:17999200
Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths. PMID:17942325
Neuropathology for the neuroradiologist: plaques and tangles. PMID:17925367
Prospects for prediction: ethics analysis of neuroimaging in Alzheimer's disease. PMID:17413029
Magnetic resonance imaging of Alzheimer's disease. PMID:16865367
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. PMID:16480900
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception PubMed citations: 177.

177 articles citing: The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

Construction of a confounder-free clinical MRI dataset in the Mass General Brigham system for classification of Alzheimer's disease. PMID:35659387
Identifying Alzheimer's genes via brain transcriptome mapping. PMID:35590321
Alzheimer's Disease Assessments Optimized for Diagnostic Accuracy and Administration Time. PMID:35557505
Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration. PMID:35228332
Weighted Brain Network Analysis on Different Stages of Clinical Cognitive Decline. PMID:35200415
Genetic Algorithms for Optimized Diagnosis of Alzheimer's Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging. PMID:35185510
Tracer-specific reference tissues selection improves detection of 18 F-FDG, 18 F-florbetapir, and 18 F-flortaucipir PET SUVR changes in Alzheimer's disease. PMID:35165964
Genome-Wide association study of quantitative biomarkers identifies a novel locus for alzheimer's disease at 12p12.1. PMID:35086473
Poor Diet, Long Sleep, and Lack of Physical Activity Are Associated with Inflammation among Non-Demented Community-Dwelling Elderly. PMID:35052306
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives. PMID:35005206
The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer's Disease. PMID:34887998
A Comparative Study of Functional Connectivity Measures for Brain Network Analysis in the Context of AD Detection with EEG. PMID:34828251
Comparing Performance of Different Predictive Models in Estimating Disease Progression in Alzheimer Disease. PMID:34393191
Life-Course Pathways to Cognitive Aging: The Significance of Intellectual Stimulation in the Form of Education and Occupation for Public Policy and Prevention Plans. PMID:34366944
Reduced coupling between cerebrospinal fluid flow and global brain activity is linked to Alzheimer disease-related pathology. PMID:34061820
Transcriptome-wide association analysis of brain structures yields insights into pleiotropy with complex neuropsychiatric traits. PMID:34001886
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease. PMID:33984181
Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects. PMID:33914757
Multi-task Dictionary Learning based on Convolutional Neural Networks for Longitudinal Clinical Score Predictions in Alzheimer's Disease. PMID:33907742
Early diagnosis of Alzheimer's disease on ADNI data using novel longitudinal score based on functional principal component analysis. PMID:33898638
Gray Matter Atrophy in Amnestic Mild Cognitive Impairment: A Voxel-Based Meta-Analysis. PMID:33867968
Interplay between stress-related genes may influence Alzheimer's disease development: The results of genetic interaction analyses of human data. PMID:33798591
Predicting future cognitive decline with hyperbolic stochastic coding. PMID:33711742
Template Independent Component Analysis: Targeted and Reliable Estimation of Subject-level Brain Networks using Big Data Population Priors. PMID:33060872
The Potential Mediation of the Effects of Physical Activity on Cognitive Function by the Gut Microbiome. PMID:32992812
Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study. PMID:32793801
ENIGMA-anxiety working group: Rationale for and organization of large-scale neuroimaging studies of anxiety disorders. PMID:32618421
Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways. PMID:32573913
Questioning the Meaning of a Change on the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Noncomparable Scores and Item-Specific Effects Over Time. PMID:32406251
Integrating Convolutional Neural Networks and Multi-Task Dictionary Learning for Cognitive Decline Prediction with Longitudinal Images. PMID:32390615
Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study. PMID:32316912
Multi-View Based Multi-Model Learning for MCI Diagnosis. PMID:32244855
Novel Alzheimer's disease subtypes identified using a data and knowledge driven strategy. PMID:31992745
Genome-wide association study of cerebrospinal fluid neurofilament light levels in non-demented elders. PMID:31930058
Detection of Alzheimer Disease Pathology in Patients Using Biochemical Biomarkers: Prospects and Challenges for Use in Clinical Practice. PMID:31848218
CHIMGEN: a Chinese imaging genetics cohort to enhance cross-ethnic and cross-geographic brain research. PMID:31827248
Predicting Longitudinal Outcomes of Alzheimer's Disease via a Tensor-Based Joint Classification and Regression Model. PMID:31797582
Inter-method and anatomical correlates of episodic memory tests in the Alzheimer's Disease spectrum. PMID:31600312
Integration of Machine Learning Methods to Dissect Genetically Imputed Transcriptomic Profiles in Alzheimer's Disease. PMID:31552082
The Contribution Plot: Decomposition and Graphical Display of the RV Coefficient, with Application to Genetic and Brain Imaging Biomarkers of Alzheimer's Disease. PMID:31430752
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis. PMID:31422457
Layer-Wise Relevance Propagation for Explaining Deep Neural Network Decisions in MRI-Based Alzheimer's Disease Classification. PMID:31417397
Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data. PMID:31386218
Fast and scalable distributed deep convolutional autoencoder for fMRI big data analytics. PMID:31354187
α-synuclein in the pathophysiology of Alzheimer's disease. PMID:31186026
APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points. PMID:31127775
Temporal Correlation Structure Learning for MCI Conversion Prediction. PMID:31106305
Cognitive Training and Transcranial Direct Current Stimulation in Mild Cognitive Impairment: A Randomized Pilot Trial. PMID:31031581
Development of a Stand-Alone Independent Graphical User Interface for Neurological Disease Prediction with Automated Extraction and Segmentation of Gray and White Matter in Brain MRI Images. PMID:30906515
High-dimensional longitudinal classification with the multinomial fused lasso. PMID:30701586
Tauopathy in veterans with long-term posttraumatic stress disorder and traumatic brain injury. PMID:30617964
Callosal thickness profiles for prognosticating conversion from mild cognitive impairment to Alzheimer's disease: A classification approach. PMID:30565884
Bayesian Functional Joint Models for Multivariate Longitudinal and Time-to-Event Data. PMID:30559575
Quantitative assessment of field strength, total intracranial volume, sex, and age effects on the goodness of harmonization for volumetric analysis on the ADNI database. PMID:30431208
Quantitative trait loci identification for brain endophenotypes via new additive model with random networks. PMID:30423101
A standard model of Alzheimer's disease? PMID:30220236
Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases. PMID:30130645
Heritability of Regional Brain Volumes in Large-Scale Neuroimaging and Genetic Studies. PMID:30010813
An efficient algorithm for estimating brain covariance networks. PMID:30001336
Using Deep Learning Algorithms to Automatically Identify the Brain MRI Contrast: Implications for Managing Large Databases. PMID:29956131
Clinical periodontal variables in patients with and without dementia-a systematic review and meta-analysis. PMID:29934798
Prion-like mechanisms in Alzheimer disease. PMID:29887142
Pediatric Brain Development in Down Syndrome: A Field in Its Infancy. PMID:29789029
Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework. PMID:29784544
The Importance of Nonlinear Transformations Use in Medical Data Analysis. PMID:29752251
Genome-wide association study identifies two loci influencing plasma neurofilament light levels. PMID:29747637
Are methodological quality and completeness of reporting associated with citation-based measures of publication impact? A secondary analysis of a systematic review of dementia biomarker studies. PMID:29572396
Conversion and time-to-conversion predictions of mild cognitive impairment using low-rank affinity pursuit denoising and matrix completion. PMID:29414437
The development of a stochastic mathematical model of Alzheimer's disease to help improve the design of clinical trials of potential treatments. PMID:29377891
β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling. PMID:29358920
Loneliness 5 years ante-mortem is associated with disease-related differential gene expression in postmortem dorsolateral prefrontal cortex. PMID:29317593
Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to. PMID:29307736
Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease. PMID:29237931
Alzheimer's Disease: Past, Present, and Future. PMID:29198280
Biomarkers of Cognitive Impairment: Brain Cortical Thickness, Volumetrics, and Cerebrospinal Fluid. PMID:29189303
Multi-stage Diagnosis of Alzheimer's Disease with Incomplete Multimodal Data via Multi-task Deep Learning. PMID:29104963
Accelerating drug development for Alzheimer's disease through the use of data standards. PMID:29067333
Translational MRI Volumetry with NeuroQuant: Effects of Version and Normative Data on Relationships with Memory Performance in Healthy Older Adults and Patients with Mild Cognitive Impairment. PMID:29060939
A New Statistical Image Analysis Approach and Its Application to Hippocampal Morphometry. PMID:28944348
Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease. PMID:28941407
The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting. PMID:28869470
Multi-Kernel Learning with Dartel Improves Combined MRI-PET Classification of Alzheimer's Disease in AIBL Data: Group and Individual Analyses. PMID:28790908
Functional joint model for longitudinal and time-to-event data: an application to Alzheimer's disease. PMID:28664662
Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis. PMID:28578726
Multi-modal classification of neurodegenerative disease by progressive graph-based transductive learning. PMID:28551556
Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration. PMID:28413716
Subjective Cognitive Impairment Is a Predominantly Benign Condition in Memory Clinic Patients Followed for 6 Years: The Gothenburg-Oslo MCI Study. PMID:28413412
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. PMID:28342697
Dissociable diffusion MRI patterns of white matter microstructure and connectivity in Alzheimer's disease spectrum. PMID:28338052
Neuroanatomical and Neuropsychological Markers of Amnestic MCI: A Three-Year Longitudinal Study in Individuals Unaware of Cognitive Decline. PMID:28275349
Selection bias in the reported performances of AD classification pipelines. PMID:28271040
Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype. PMID:28269787
Fear and Uncertainty Do Not Influence Reported Willingness to Undergo Lumbar Punctures in a U.S. Multi-Cultural Cohort. PMID:28239349
Comparisons of neurodegeneration over time between healthy ageing and Alzheimer's disease cohorts via Bayesian inference. PMID:28174220
The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. PMID:27931796
Real-Time fMRI in Neuroscience Research and Its Use in Studying the Aging Brain. PMID:27803662
Quantitative multimodal multiparametric imaging in Alzheimer's disease. PMID:27747597
Identifying significant gene-environment interactions using a combination of screening testing and hierarchical false discovery rate control. PMID:27578615
Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration. PMID:27547726
Homogeneous clusters of Alzheimer's disease patient population. PMID:27453981
Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action. PMID:27375473
Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers. PMID:27239548
Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia. PMID:27239524
Revolutionizing Alzheimer's disease and clinical trials through biomarkers. PMID:27239522
Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers. PMID:27239505
Introducing Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, an open access journal of the Alzheimer's Association. PMID:27239487
Enhancing latent cognitive capacity in mild cognitive impairment with gist reasoning training: a pilot study. PMID:27112124
STGP: Spatio-temporal Gaussian process models for longitudinal neuroimaging data. PMID:27103140
Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases. PMID:27061068
Joint Diagnosis and Conversion Time Prediction of Progressive Mild Cognitive Impairment (pMCI) Using Low-Rank Subspace Clustering and Matrix Completion. PMID:27054201
Optimization of brain PET imaging for a multicentre trial: the French CATI experience. PMID:27044410
A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS). PMID:27019841
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment. PMID:26976043
Incidental Intracranial Findings and Their Clinical Impact; The HUNT MRI Study in a General Population of 1006 Participants between 50-66 Years. PMID:26950220
NO2 inhalation promotes Alzheimer's disease-like progression: cyclooxygenase-2-derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication. PMID:26928013
Control-group feature normalization for multivariate pattern analysis of structural MRI data using the support vector machine. PMID:26915498
Role of Hybrid Brain Imaging in Neuropsychiatric Disorders. PMID:26854172
Surface-Based Morphometric Analysis of Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer's Disease. PMID:26778923
Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment. PMID:26768154
Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts. PMID:26742530
Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease. PMID:26659895
Identification of progressive mild cognitive impairment patients using incomplete longitudinal MRI scans. PMID:26603378
The effects of tamoxifen on spatial and nonspatial learning and memory impairments induced by scopolamine and the brain tissues oxidative damage in ovariectomized rats. PMID:26601084
Genetic Interactions Explain Variance in Cingulate Amyloid Burden: An AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort. PMID:26421299
Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease. PMID:26402410
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. PMID:26341365
Pharmacological MRI (phMRI) of the Human Central Nervous System. PMID:26329611
The Global Alzheimer's Association Interactive Network. PMID:26318022
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. PMID:26220940
Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies. PMID:26219595
Neuropathologic correlates of regional brain volumes in a community cohort of older adults. PMID:26195068
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. PMID:26194320
The Alzheimer's Disease Neuroimaging Initiative informatics core: A decade in review. PMID:26194316
The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding. PMID:26194315
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. PMID:26194313
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans. PMID:26194312
Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative. PMID:26194308
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up. PMID:26174331
Imaging-based enrichment criteria using deep learning algorithms for efficient clinical trials in mild cognitive impairment. PMID:26093156
Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings. PMID:26085606
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. PMID:26073027
Imaging in StrokeNet: Realizing the Potential of Big Data. PMID:26045600
Verbal Fluency and Early Memory Decline: Results from the Wisconsin Registry for Alzheimer's Prevention. PMID:26025231
The Image and Data Archive at the Laboratory of Neuro Imaging. PMID:25982516
Novel Neuroimaging Methods to Understand How HIV Affects the Brain. PMID:25902966
Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratio. PMID:25873425
Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease. PMID:25822737
EEG Spectral Features Discriminate between Alzheimer's and Vascular Dementia. PMID:25762978
Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer's Disease Neuroimaging Initiative. PMID:25614473
A kernel machine method for detecting effects of interaction between multidimensional variable sets: an imaging genetics application. PMID:25600633
Role of cerebrospinal fluid biomarkers in clinical trials for Alzheimer's disease modifying therapies. PMID:25598657
Antibody-derived in vivo imaging of tau pathology. PMID:25505335
Imaging as a biomarker in drug discovery for Alzheimer's disease: is MRI a suitable technology? PMID:25484927
Blood biomarkers for Alzheimer's disease. PMID:25473432
Unbiased approaches to biomarker discovery in neurodegenerative diseases. PMID:25442938
Partial volume effect modeling for segmentation and tissue classification of brain magnetic resonance images: A review. PMID:25431640
Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets. PMID:25402421
Association of cancer history with Alzheimer's disease onset and structural brain changes. PMID:25400589
FASTKD2 is associated with memory and hippocampal structure in older adults. PMID:25385369
Cortical hypermetabolism in MCI subjects: a compensatory mechanism? PMID:25267349
Key network approach reveals new insight into Alzheimer's disease. PMID:25075530
mNos2 deletion and human NOS2 replacement in Alzheimer disease models. PMID:25003233
Alzheimer's disease risk genes and mechanisms of disease pathogenesis. PMID:24951455
The Combination of Dysexecutive and Amnestic Deficits Strongly Predicts Conversion to Dementia in Young Mild Cognitive Impairment Patients: A Report from the Gothenburg-Oslo MCI Study. PMID:24847346
Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments. PMID:24807087
Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors. PMID:24795626
CR1 in Alzheimer's disease. PMID:24794147
The neurobiological basis of cognitive impairment in Parkinson's disease. PMID:24757112
Cost-effectiveness analyses in multiple sclerosis: a review of modelling approaches. PMID:24643323
Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. PMID:24602322
Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity. PMID:24591589
The growth and impact of Alzheimer disease centers as measured by social network analysis. PMID:24514750
Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study. PMID:24368295
A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative. PMID:24367935
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research. PMID:24327327
Clinical and multimodal biomarker correlates of ADNI neuropathological findings. PMID:24252435
Neuroimaging biomarkers of neurodegenerative diseases and dementia. PMID:24234359
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception PubMed citations: 133.

133 articles citing: 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

The Clinical Course of Early and Late Mild Cognitive Impairment. PMID:35651352
MuscNet, a Weighted Voting Model of Multi-Source Connectivity Networks to Predict Mild Cognitive Impairment Using Resting-State Functional MRI. PMID:35548102
Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers. PMID:35493930
Operationalising fairness in medical AI adoption: detection of early Alzheimer's disease with 2D CNN. PMID:35477689
Development of Alzheimer's Disease Biomarkers: From CSF- to Blood-Based Biomarkers. PMID:35453600
Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer´s disease patients. PMID:34957735
Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer's Disease With High Performance Computing. PMID:34957393
It Is Time to Study Overlapping Molecular and Circuit Pathophysiologies in Alzheimer's and Lewy Body Disease Spectra. PMID:34867224
Dimensionality Reduction: Foundations and Applications in Clinical Neuroscience. PMID:34862528
Information Flow Pattern in Early Mild Cognitive Impairment Patients. PMID:34858306
Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease. PMID:34856902
Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum. PMID:34647694
Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer's disease pathology and cognitive function. PMID:34615471
Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics? PMID:34575610
Head injury is associated with tau deposition on PET in MCI and AD patients. PMID:34466653
DeepAtrophy: Teaching a neural network to detect progressive changes in longitudinal MRI of the hippocampal region in Alzheimer's disease. PMID:34450261
Association of Osteoarthritis With Changes in Structural Neuroimaging Markers Over Time Among Non-demented Older Adults. PMID:34447303
Association of Tau Pathology With Clinical Symptoms in the Subfields of Hippocampal Formation. PMID:34335226
Assessing Clinical Change in Individuals Exposed to Repetitive Head Impacts: The Repetitive Head Impact Composite Index. PMID:34295295
Protocol for magnetic resonance imaging acquisition, quality assurance, and quality check for the Accelerator program for Discovery in Brain disorders using Stem cells. PMID:33960571
Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies. PMID:33931975
Quantitative Analysis of Synthetic Magnetic Resonance Imaging in Alzheimer's Disease. PMID:33912023
System-Level Analysis of Alzheimer's Disease Prioritizes Candidate Genes for Neurodegeneration. PMID:33889174
Interplay between stress-related genes may influence Alzheimer's disease development: The results of genetic interaction analyses of human data. PMID:33798591
Brain/MINDS beyond human brain MRI project: A protocol for multi-level harmonization across brain disorders throughout the lifespan. PMID:33741307
Cerebral amyloid-β load is associated with neurodegeneration and gliosis: Mediation by p-tau and interactions with risk factors early in the Alzheimer's continuum. PMID:33663013
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review. PMID:33551785
Comparison of regional brain deficit patterns in common psychiatric and neurological disorders as revealed by big data. PMID:33530016
Construction of MRI-Based Alzheimer's Disease Score Based on Efficient 3D Convolutional Neural Network: Comprehensive Validation on 7,902 Images from a Multi-Center Dataset. PMID:33252079
The power of knowledge about dementia in Latin America across health professionals working on aging. PMID:33088898
Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia. PMID:33005724
The Aging Slopes of Brain Structures Vary by Ethnicity and Sex: Evidence From a Large Magnetic Resonance Imaging Dataset From a Single Scanner of Cognitively Healthy Elderly People in Korea. PMID:32903525
The Regulating Mechanism of Chrysophanol on Protein Level of CaM-CaMKIV to Protect PC12 Cells Against Aβ25-35-Induced Damage. PMID:32764873
Applying surface-based morphometry to study ventricular abnormalities of cognitively unimpaired subjects prior to clinically significant memory decline. PMID:32683323
Molecular and Imaging Biomarkers in Alzheimer's Disease: A Focus on Recent Insights. PMID:32664352
Longitudinal ComBat: A method for harmonizing longitudinal multi-scanner imaging data. PMID:32640273
Genetic architecture of Alzheimer's disease. PMID:32565066
Interleukin-6 Treatment Results in GLUT4 Translocation and AMPK Phosphorylation in Neuronal SH-SY5Y Cells. PMID:32365859
Non-coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases. PMID:32330418
Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study. PMID:32310181
Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer's Disease. PMID:32226377
Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease. PMID:32106025
Patient Input to Inform the Development of Central Nervous System Outcome Measures in Myotonic Dystrophy. PMID:31970692
Network Medicine Approach for Analysis of Alzheimer's Disease Gene Expression Data. PMID:31947790
Association of brain amyloidosis with the incidence and frequency of neuropsychiatric symptoms in ADNI: a multisite observational cohort study. PMID:31857304
CHIMGEN: a Chinese imaging genetics cohort to enhance cross-ethnic and cross-geographic brain research. PMID:31827248
Serial position effects rapidly distinguish Alzheimer's from frontotemporal dementia. PMID:31807915
Deep learning-based classification of multi-categorical Alzheimer's disease data. PMID:31798274
Amyloid PET Quantification Via End-to-End Training of a Deep Learning. PMID:31723364
Genome-wide association study identifies SIAH3 locus influencing the rate of ventricular enlargement in non-demented elders. PMID:31711042
Decreased retinal thickness in patients with Alzheimer's disease is correlated with disease severity. PMID:31689310
Computational analysis of functional SNPs in Alzheimer's disease-associated endocytosis genes. PMID:31592138
Early diagnosis of Alzheimer's disease using combined features from voxel-based morphometry and cortical, subcortical, and hippocampus regions of MRI T1 brain images. PMID:31584953
Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images. PMID:31552787
Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data. PMID:31386218
In vivo magnetic resonance imaging and spectroscopy. Technological advances and opportunities for applications continue to abound. PMID:31377150
Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort. PMID:31322561
Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time. PMID:31286994
A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data. PMID:31201098
Oral Immunization with Soybean Storage Protein Containing Amyloid-β 4-10 Prevents Spatial Learning Decline. PMID:31177217
Differentiating Between Healthy Control Participants and Those with Mild Cognitive Impairment Using Volumetric MRI Data. PMID:31130145
Incorporating spatial-anatomical similarity into the VGWAS framework for AD biomarker detection. PMID:31095298
Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease. PMID:30904851
Screening for Dementia Caused by Modifiable Lifestyle Choices Using Hybrid PET/MRI. PMID:30842996
Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease. PMID:30704519
Tauopathy in veterans with long-term posttraumatic stress disorder and traumatic brain injury. PMID:30617964
The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach. PMID:30554402
Identification of Differentially Expressed Profiles of Alzheimer's Disease Associated Circular RNAs in a Panax Notoginseng Saponins-Treated Alzheimer's Disease Mouse Model. PMID:30524667
Generation and quality control of lipidomics data for the alzheimer's disease neuroimaging initiative cohort. PMID:30457571
Observational Study of Clinical and Functional Progression Based on Initial Brain MRI Characteristics in Patients with Alzheimer's Disease. PMID:30452413
Aging and APOE-ε4 are determinative factors of plasma Aβ42 levels. PMID:30349853
Compressed Sensing Diffusion Spectrum Imaging for Accelerated Diffusion Microstructure MRI in Long-Term Population Imaging. PMID:30319336
The etiological effect of a new low-frequency ESR1 variant on Mild Cognitive Impairment and Alzheimer's Disease: a population-based study. PMID:30222591
The price of progress: Funding and financing Alzheimer's disease drug development. PMID:30175227
PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases. PMID:30075287
Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder. PMID:30035339
A preclinical perspective on the enhanced vulnerability to Alzheimer's disease after early-life stress. PMID:29888312
A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. PMID:29843242
Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework. PMID:29784544
Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET. PMID:29736165
A Neuroimaging Web Services Interface as a Cyber Physical System for Medical Imaging and Data Management in Brain Research: Design Study. PMID:29699962
GPU Accelerated Browser for Neuroimaging Genomics. PMID:29691798
An ensemble learning system for a 4-way classification of Alzheimer's disease and mild cognitive impairment. PMID:29578038
Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment: a critical review. PMID:29458420
Comprehensive analysis of differentially expressed profiles of Alzheimer's disease associated circular RNAs in an Alzheimer's disease mouse model. PMID:29448241
Classification of MRI and psychological testing data based on support vector machine. PMID:29445429
Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies. PMID:29391909
Editorial: Collaborative Efforts to Prevent Alzheimer's Disease. PMID:29188862
Current Role for Biomarkers in Clinical Diagnosis of Alzheimer Disease and Frontotemporal Dementia. PMID:29134465
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. PMID:29121998
Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative. PMID:29095836
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. PMID:29076399
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline. PMID:29070667
Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. PMID:29025866
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. PMID:29017593
Entorhinal and transentorhinal atrophy in mild cognitive impairment using longitudinal diffeomorphometry. PMID:28971142
Advances in Studying Brain Morphology: The Benefits of Open-Access Data. PMID:28824407
Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts. PMID:28790911
Effects of traumatic brain injury and posttraumatic stress disorder on development of Alzheimer's disease in Vietnam Veterans using the Alzheimer's Disease Neuroimaging Initiative: Preliminary Report. PMID:28758146
Dynamic predictions in Bayesian functional joint models for longitudinal and time-to-event data: An application to Alzheimer's disease. PMID:28750578
Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies. PMID:28733956
Functional joint model for longitudinal and time-to-event data: an application to Alzheimer's disease. PMID:28664662
NPTX2 and cognitive dysfunction in Alzheimer's Disease. PMID:28440221
The C677T variant in MTHFR modulates associations between brain integrity, mood, and cognitive functioning in old age. PMID:28435933
A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages. PMID:28414186
A Hierarchical Feature and Sample Selection Framework and Its Application for Alzheimer's Disease Diagnosis. PMID:28358032
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. PMID:28342697
Repetitive head impact exposure and later-life plasma total tau in former National Football League players. PMID:28229128
Identification of Early-Stage Alzheimer's Disease Using Sulcal Morphology and Other Common Neuroimaging Indices. PMID:28129351
Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden. PMID:28031319
Strategies for Utilizing Neuroimaging Biomarkers in CNS Drug Discovery and Development: CINP/JSNP Working Group Report. PMID:28031269
The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. PMID:27931796
The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis. PMID:27924371
Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives. PMID:27833399
Biomarkers for the Early Detection and Progression of Alzheimer's Disease. PMID:27738903
Exploring and visualizing multidimensional data in translational research platforms. PMID:27585944
The superior fault tolerance of artificial neural network training with a fault/noise injection-based genetic algorithm. PMID:27502185
APPLYING SPARSE CODING TO SURFACE MULTIVARIATE TENSOR-BASED MORPHOMETRY TO PREDICT FUTURE COGNITIVE DECLINE. PMID:27499829
Les nouveaux critères de la Maladie d'Alzheimer - Perspective gériatrique. PMID:27403215
The New Criteria for Alzheimer's Disease - Implications for Geriatricians. PMID:27403214
Quantitative T2 mapping of white matter: applications for ageing and cognitive decline. PMID:27384985
Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease. PMID:27378911
Power spectrum density analysis for the influence of complete denture on the brain function of edentulous patients - pilot study. PMID:27350852
Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. PMID:27229352
Molecular and cellular pathophysiology of preclinical Alzheimer's disease. PMID:27185734
Toward precision medicine in neurological diseases. PMID:27127757
Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. PMID:26950278
Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy. PMID:26890775
An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia. PMID:26812251
Recent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment. PMID:26590911
Common polygenic variation enhances risk prediction for Alzheimer's disease. PMID:26490334
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. PMID:26194320
Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative. PMID:26194308
https://doi.org/10.1212/WNL.0b013e3181cb3e25

Tags:

Tags
More detailed information about this field from each metasource.

aging
metasource: Fairsharing.org
version: FAIRsharing.org: IDA; LONI Image Data Archive; DOI: https://doi.org/10.25504/FAIRsharing.r4ph5f; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:08 p.m.

brain imaging
metasource: Fairsharing.org
version: FAIRsharing.org: IDA; LONI Image Data Archive; DOI: https://doi.org/10.25504/FAIRsharing.r4ph5f; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:08 p.m.

disease course
metasource: Fairsharing.org
version: FAIRsharing.org: IDA; LONI Image Data Archive; DOI: https://doi.org/10.25504/FAIRsharing.r4ph5f; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:08 p.m.

imaging
metasource: Fairsharing.org
version: FAIRsharing.org: IDA; LONI Image Data Archive; DOI: https://doi.org/10.25504/FAIRsharing.r4ph5f; Last edited: Jan. 8, 2019, 1:21 p.m.; Last accessed: Jan 03 2022 7:08 p.m.

alzheimer
metasource: re3data.org
version: re3data.org: Alzheimer's Disease Neuroimaging Initiative Image and Data Archive; editing status 2020-08-20; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMTE last accessed: 2022-11-04

biosamples
metasource: re3data.org
version: re3data.org: Alzheimer's Disease Neuroimaging Initiative Image and Data Archive; editing status 2020-08-20; re3data.org - Registry of Research Data Repositories. http://doi.org/10.17616/R31NJMTE last accessed: 2022-11-04

aging brain imaging disease course imaging alzheimer biosamples

More to explore:

1/20

Previous Next

Need help integrating and/or managing biomedical data?

Webpage:

Licence:

More to explore:

1/20

Image and Data Quality Assessment Ontology

National Institute of Mental Health Data Archive

ETH Data Archive

Alzheimer's Disease Ontology

Australian Data Archive

Neuroimaging Informatics Tools and Resources Collaboratory Resources Registry

Neuroimaging Informatics Tools and Resources Collaboratory Image Repository

OASIS

Bilingual Ontology of Alzheimer's Disease and Related Diseases

National Aeronautics and Space Administration Image and Video Gallery

Alzheimer Disease & Frontotemporal Dementia Mutation Database

Electron Microscope Public Image Archive

e!DAL - electronic Data Archive Library

Forest Service Research Data Archive

Population Health Data Archive

Neuroimaging Data Model

Alzforum

NEMAR

Image Attribution Framework Development Repository

Alzheimer Disease Relevance Ontology by Process